Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Breast Cancer

  Free Subscription


20.01.2020

1 AJR Am J Roentgenol
3 Ann Oncol
2 Ann Surg Oncol
5 Br J Cancer
3 Breast Cancer
3 Breast Cancer Res
3 Breast Cancer Res Treat
3 Breast J
2 Cancer Epidemiol Biomarkers Prev
1 Cancer Res
1 Carcinogenesis
4 Clin Breast Cancer
3 Clin Cancer Res
1 Clin Exp Metastasis
3 Eur J Cancer
1 Int J Oncol
3 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Nucl Med
1 J Surg Oncol
3 JAMA
1 NPJ Breast Cancer
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. VOLTERRANI L, Gentili F, Fausto A, Pelini V, et al
    Dual-Energy CT for Locoregional Staging of Breast Cancer: Preliminary Results.
    AJR Am J Roentgenol. 2020 Jan 15:1-8. doi: 10.2214/AJR.18.20953.
    PubMed     Text format     Abstract available


    Ann Oncol

  2. VERRET B, Cortes J, Bachelot T, Andre F, et al
    Efficacy of PI3K inhibitors in advanced breast cancer.
    Ann Oncol. 2019;30 Suppl 10:x12-x20.
    PubMed     Text format     Abstract available

  3. BRANDAO M, Caparica R, Eiger D, de Azambuja E, et al
    Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors.
    Ann Oncol. 2019;30 Suppl 10:x27-x42.
    PubMed     Text format     Abstract available

  4. VASAN N, Toska E, Scaltriti M
    Overview of the relevance of PI3K pathway in HR-positive breast cancer.
    Ann Oncol. 2019;30 Suppl 10:x3-x11.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  5. GROHEUX D, Hindie E
    (18)FDG-PET/CT Imaging in Breast Cancer Patients with Clinical Stage IIB or Higher : Commentary on "Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer" by Marissa K. Srour et al.
    Ann Surg Oncol. 2020 Jan 13. pii: 10.1245/s10434-019-08188.
    PubMed     Text format    

  6. ZUCCA-MATTHES G, Lebovic G
    Reflection on Consensus Statement on Oncoplastic Surgery.
    Ann Surg Oncol. 2019;26:3005-3006.
    PubMed     Text format    


    Br J Cancer

  7. HARVIE M, Pegington M, Bundred N, Campbell A, et al
    Reply to Comment on "The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial".
    Br J Cancer. 2020 Jan 14. pii: 10.1038/s41416-019-0715.
    PubMed     Text format    

  8. AHN S, Kim HJ, Kang E, Kim EK, et al
    Genomic profiling of multiple breast cancer reveals inter-lesional heterogeneity.
    Br J Cancer. 2020 Jan 13. pii: 10.1038/s41416-019-0713.
    PubMed     Text format     Abstract available

  9. BAIL JR, Halilova KI, Demark-Wahnefried W, Reeves MM, et al
    Comment on "The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial".
    Br J Cancer. 2020 Jan 14. pii: 10.1038/s41416-019-0714.
    PubMed     Text format    

  10. MULL BB, Livingston JA, Patel N, Bui T, et al
    Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer.
    Br J Cancer. 2020 Jan 16. pii: 10.1038/s41416-019-0707.
    PubMed     Text format     Abstract available

  11. CASCIANO JC, Perry C, Cohen-Nowak AJ, Miller KD, et al
    MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer.
    Br J Cancer. 2020 Jan 16. pii: 10.1038/s41416-019-0711.
    PubMed     Text format     Abstract available


    Breast Cancer

  12. HUANG M, Wu J, Ling R, Li N, et al
    Quadruple negative breast cancer.
    Breast Cancer. 2020 Jan 14. pii: 10.1007/s12282-020-01047.
    PubMed     Text format     Abstract available

  13. GOTO R, Hirota Y, Aruga T, Horiguchi S, et al
    The number of FoxP3-positive tumor-infiltrating lymphocytes in patients with synchronous bilateral breast cancer.
    Breast Cancer. 2020 Jan 13. pii: 10.1007/s12282-020-01049.
    PubMed     Text format     Abstract available

  14. LIU Y, Wang J, Su R, Tang Y, et al
    Postoperative radiotherapy-induced leiomyosarcoma in breast cancer: a case report and literature review.
    Breast Cancer. 2020 Jan 11. pii: 10.1007/s12282-020-01050.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  15. HEATH AK, Muller DC, van den Brandt PA, Papadimitriou N, et al
    Nutrient-wide association study of 92 foods and nutrients and breast cancer risk.
    Breast Cancer Res. 2020;22:5.
    PubMed     Text format     Abstract available

  16. GOLDSTEIN LJ, Perez RP, Yardley D, Han LK, et al
    A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer.
    Breast Cancer Res. 2020;22:4.
    PubMed     Text format     Abstract available

  17. LEWIS K, Kiepas A, Hudson J, Senecal J, et al
    p66ShcA functions as a contextual promoter of breast cancer metastasis.
    Breast Cancer Res. 2020;22:7.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  18. BJERKESET E, Rohrl K, Schou-Bredal I
    Symptom cluster of pain, fatigue, and psychological distress in breast cancer survivors: prevalence and characteristics.
    Breast Cancer Res Treat. 2020 Jan 14. pii: 10.1007/s10549-020-05522.
    PubMed     Text format     Abstract available

  19. TADROS AB, Moo TA, Stempel M, Zabor EC, et al
    Axillary management for young women with breast cancer varies between patients electing breast-conservation therapy or mastectomy.
    Breast Cancer Res Treat. 2020 Jan 14. pii: 10.1007/s10549-019-05520.
    PubMed     Text format     Abstract available

  20. ROTILI A, Trimboli RM, Penco S, Pesapane F, et al
    Double reading of diffusion-weighted magnetic resonance imaging for breast cancer detection.
    Breast Cancer Res Treat. 2020 Jan 14. pii: 10.1007/s10549-019-05519.
    PubMed     Text format     Abstract available


    Breast J

  21. MORAN MS, Truong PT
    Hypofractionated radiation treatment for breast cancer: The time is now.
    Breast J. 2020 Jan 15. doi: 10.1111/tbj.13724.
    PubMed     Text format     Abstract available

  22. MACDONALD HR
    Pregnancy associated breast cancer.
    Breast J. 2020 Jan 14. doi: 10.1111/tbj.13714.
    PubMed     Text format     Abstract available

  23. WOOD ME, Garber JE, Isaacs C, Masood S, et al
    Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations.
    Breast J. 2019;25:575-577.
    PubMed     Text format    


    Cancer Epidemiol Biomarkers Prev

  24. AHERN TP, Collin LJ, Baurley JW, Kjaersgaard A, et al
    Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2020 Jan 13. pii: 1055-9965.EPI-19-0833.
    PubMed     Text format     Abstract available

  25. HENG YJ, Hankinson SE, Wang J, Alexandrov LB, et al
    The association of modifiable breast cancer risk factors and somatic genomic alterations in breast tumors: The Cancer Genome Atlas Network.
    Cancer Epidemiol Biomarkers Prev. 2020 Jan 13. pii: 1055-9965.EPI-19-1087.
    PubMed     Text format     Abstract available


    Cancer Res

  26. ECKHARDT BL, Cao Y, Redfern AD, Chi LH, et al
    Activation of canonical BMP4-SMAD7 signaling suppresses breast cancer metastasis.
    Cancer Res. 2020 Jan 15. pii: 0008-5472.CAN-19-0743.
    PubMed     Text format     Abstract available


    Carcinogenesis

  27. UDQUIM KI, Zettelmeyer C, Banday AR, Lin SH, et al
    APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
    Carcinogenesis. 2020 Jan 13. pii: 5700878. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  28. BINES J, Procter M, Restuccia E, Viale G, et al
    Incidence and Management of Diarrhea With Adjuvant Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    Clin Breast Cancer. 2019 Sep 5. pii: S1526-8209(19)30656.
    PubMed     Text format     Abstract available

  29. YARDLEY DA, Liggett W, Mainwaring M, Castrellon A, et al
    A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
    Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30164.
    PubMed     Text format     Abstract available

  30. TKACZUK KHR, Hawkins D, Yue B, Hicks D, et al
    Association of Serum Progranulin Levels With Disease Progression, Therapy Response and Survival in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Dec 5. pii: S1526-8209(19)30758.
    PubMed     Text format     Abstract available

  31. HOPSON MB, Onishi M, Awad D, Buono D, et al
    Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy.
    Clin Breast Cancer. 2019 Dec 5. pii: S1526-8209(19)30759.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  32. MCCARTNEY A, Bonechi M, De Luca F, Biagioni C, et al
    Plasma thymidine kinase activity as a biomarker in patients with luminal metastatic breast cancer treated with palbociclib within the TREnd trial.
    Clin Cancer Res. 2020 Jan 14. pii: 1078-0432.CCR-19-3271.
    PubMed     Text format     Abstract available

  33. KARN T, Meissner T, Weber K, Solbach C, et al
    A small hypoxia signature predicted pCR response to bevacizumab in the neoadjuvant GeparQuinto breast cancer trial.
    Clin Cancer Res. 2020 Jan 13. pii: 1078-0432.CCR-19-1954.
    PubMed     Text format     Abstract available

  34. BAM R, Lown PS, Stern LA, Sharma K, et al
    Efficacy of affibody-based ultrasound molecular imaging of vascular B7-H3 for breast cancer detection.
    Clin Cancer Res. 2020 Jan 10. pii: 1078-0432.CCR-19-1655.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  35. ALZUBI MA, Boyd DC, Harrell JC
    The utility of the "Glowing Head" mouse for breast cancer metastasis research.
    Clin Exp Metastasis. 2020 Jan 14. pii: 10.1007/s10585-020-10020.
    PubMed     Text format     Abstract available


    Eur J Cancer

  36. CLATOT F, Fontanilles M, Lefebvre L, Lequesne J, et al
    Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
    Eur J Cancer. 2020;126:116-124.
    PubMed     Text format     Abstract available

  37. ZIELONKE N, Gini A, Jansen EEL, Anttila A, et al
    Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: A systematic review.
    Eur J Cancer. 2020 Jan 10. pii: S0959-8049(19)30863.
    PubMed     Text format     Abstract available

  38. SAMUEL E, Chiang C, Jennens R, Faulkner D, et al
    Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer.
    Eur J Cancer. 2020;126:104-105.
    PubMed     Text format    


    Int J Oncol

  39. LEE KS, Nam GS, Baek J, Kim S, et al
    Inhibition of TPAinduced metastatic potential by morin hydrate in MCF7 human breast cancer cells via the Akt/GSK3beta/cFos signaling pathway.
    Int J Oncol. 2020 Jan 2. doi: 10.3892/ijo.2020.4954.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  40. ALMAHARIQ MF, Maywood MJ, Levitin RB, Squires BS, et al
    Mapping of Metastatic Level I Axillary Lymph Nodes in Patients with Newly Diagnosed Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 9. pii: S0360-3016(19)34519.
    PubMed     Text format     Abstract available

  41. LEE H, MacDonald SM
    Multifocal Angiosarcoma Secondary to Partial Breast Irradiation: Reirradiate?
    Int J Radiat Oncol Biol Phys. 2019;105:17-18.
    PubMed     Text format    

  42. BRADLEY JA, Bellon JR
    Quality of Life and Limb: Reducing Lymphedema Risk After Breast Cancer Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:225-229.
    PubMed     Text format    


    J Clin Oncol

  43. ALLISON KH, Hammond MEH, Dowsett M, McKernin SE, et al
    Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.
    J Clin Oncol. 2020 Jan 13:JCO1902309. doi: 10.1200/JCO.19.02309.
    PubMed     Text format     Abstract available


    J Nucl Med

  44. LAFFON E, Marthan R
    SUVmax-V for assessing treatment response in FDG-PET Imaging of Patient-Derived Tumor Xenografts involving Triple-Negative Breast Cancer.
    J Nucl Med. 2020 Jan 10. pii: jnumed.120.241778. doi: 10.2967/jnumed.120.241778.
    PubMed     Text format    


    J Surg Oncol

  45. WANG K, Dai Y, Pan Y, Cheng P, et al
    Local-regional recurrence risk after autologous fat grafting in breast cancer patients: A systematic review and meta-analysis.
    J Surg Oncol. 2020 Jan 14. doi: 10.1002/jso.25829.
    PubMed     Text format     Abstract available


    JAMA

  46. KRIST AH, Owens DK, Mangione CM
    Recommendations Related to Genetic Testing for Breast Cancer-Reply.
    JAMA. 2020;323:188-189.
    PubMed     Text format    

  47. DORK T, Park-Simon TW, Hillemanns P
    Recommendations Related to Genetic Testing for Breast Cancer.
    JAMA. 2020;323:188.
    PubMed     Text format    

  48. PINSKY PF
    Recommendations Related to Genetic Testing for Breast Cancer.
    JAMA. 2020;323:187-188.
    PubMed     Text format    


    NPJ Breast Cancer

  49. GIRO-PERAFITA A, Luo L, Khodadadi-Jamayran A, Thompson M, et al
    LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.
    NPJ Breast Cancer. 2020;6:1.
    PubMed     Text format     Abstract available


    PLoS One

  50. AL-WAJEEH AS, Salhimi SM, Al-Mansoub MA, Khalid IA, et al
    Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    PLoS One. 2020;15:e0227404.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  51. BLOCKHUYS S, Zhang X, Wittung-Stafshede P
    Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration.
    Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 1910722117.
    PubMed     Text format     Abstract available


    Radiother Oncol

  52. PONS-TOSTIVINT E, Kirova Y, Lusque A, Campone M, et al
    Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
    Radiother Oncol. 2020;145:109-116.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: